Translumina GmbH
Coronary Drug-Eluting Stents
Translumina GmbH was established in 2000 and since then has developed into a leading company in the production and development of innovative and biocompatible coronary Catheter- and Stent Systems. The drug-eluting stents Yukon Choice PC and Yukon Chrome PC have been tested in long-term clinical studies and the products are recommended from leading cardiological societies. Since 2019 Translumina GmbH Germany is working successfully together with the Indian partner company Translumina Therapeutics under the new international name Translumina - Limitless Possibilities.
Category | Medical technology |
---|---|
Working areas | Biomaterials, Development, Healthcare, Trade/Distribution, Medical products |
Year of foundation | |
Employees |
Contact
Translumina GmbH
Neue Rottenburger Straße 50
72379 Hechingen
+49 7471 9894-0
boris.behnisch@translumina.de
https://translumina.com/
Neue Rottenburger Straße 50
72379 Hechingen
+49 7471 9894-0
boris.behnisch@translumina.de
https://translumina.com/
Contact person
Dr. Boris Behnisch, Business Development